Skip to Main Content

Paper Details

Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) after Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage.
Ocul Immunol Inflamm
3
2022
Author NameAffiliation
Charles Stephen FosterMassachusetts Eye Research and Surgery Institution
Charles Stephen FosterThe Ocular Immunology and Uveitis Foundation
Charles Stephen FosterHarvard Medical School
  • 1 - 3

Datasets

Release 1.2